ArticleHeliyon2024
Environmental, social, and governance performance, financing constraints, and corporate investment efficiency: Empirical evidence from China.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- How to promote healthy ageing among disabled older adults: from a group difference perspective and function-specific pathway models.International journal for equity in health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study explores the connection between environmental, social, and governance (ESG) performance, financing constraints, and corporate investment efficiency. The hypotheses in this study are formulated based on the principles of stakeholder and agency theories. We used secondary data from Chinese A-share listed companies from 2010 to 2021 to conduct an empirical analysis using the Ordinary Least Squares (OLS) and Fixed Effect (FE) estimators. The results indicate that good ESG performance can enhance corporate investment efficiency. Compared to over-investment, ESG performance has a more pronounced effect on mitigating under-investment. Using a mediating analysis model, we also find that ESG performance exerts an inhibitory influence on both under- and over-investments by mitigating corporate financing constraints. Heterogeneity analysis indicates that the enhancing effect of ESG performance on corporate investment efficiency is more significant in non-state-owned corporations, low-pollution corporations, and corporations with a higher proportion of institutional investors. This study provides insights for listed companies to improve ESG performance to enhance capital allocation efficiency and promote sustainable development.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.